コラーゲン・ゼラチン市場：供給源別（牛、豚、海産物）、用途別（創傷治療、整形外科、心臓血管、歯科、外科、神経修復）、エンドユーザー別（病院、外科センター）、地域別 - 2028年までの世界予測

Collagen and Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopaedic, Cardiovascular, Dental, Surgical, Nerve Repair), End User (Hospitals, Surgical Centers), Region - Global Forecast to 2028

世界のコラーゲン・ゼラチン市場規模は、2023年の12億米ドルから2028年には16億米ドルに達すると予測され、予測期間中の年平均成長率は6.5%である。コラーゲンとゼラチンの創傷治療用途への採用の増加や、コラー... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年7月12日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	234	271	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界のコラーゲン・ゼラチン市場規模は、2023年の12億米ドルから2028年には16億米ドルに達すると予測され、予測期間中の年平均成長率は6.5%である。コラーゲンとゼラチンの創傷治療用途への採用の増加や、コラーゲンとゼラチンの研究への資金提供の増加などの要因が、市場の成長を促進している。心臓血管手術の増加も市場成長にプラスの影響を与えそうだ。
"コラーゲン・ゼラチン市場において、予測期間中、供給源別ではウシセグメントが圧倒的なシェアを占めた。"
供給源に基づき、世界のコラーゲン・ゼラチン市場はウシ、ブタ、その他の供給源に区分される。豚由来セグメントは2022年に最大のシェアを占めた。これは主に、組織工学におけるその高い広範な使用と創傷治療用途の生体材料の需要増加によるものである。生体適合性、構造的支持、保湿性など様々な要因により、様々な創傷治療用途で牛由来コラーゲン製品の使用が増加している。
"整形外科セグメントは、2022年にアプリケーションセグメントで最大のシェアを占めた。"
用途別では、世界のコラーゲン市場は、創傷ケア、歯科、整形外科、外科、心臓血管に区分される。ゼラチンの世界市場は、整形外科、創傷治療、その他の用途に区分される。2022年のコラーゲン・ゼラチン市場で最大のシェアを占めたのは整形外科分野であった。このセグメントの優位性は、様々な整形外科手術におけるゼラチンおよびコラーゲンベースの製品の使用の増加、および足場に対する需要の増加に起因する。
"アジア太平洋地域はより速いペースで成長する可能性が高い"
コラーゲン・ゼラチン市場は、北米、アジア太平洋、ヨーロッパ、その他の地域に区分される。アジア太平洋地域は大きなCAGRで成長すると予想されている。この地域の成長は、慢性創傷の有病率の増加と慢性潰瘍に苦しむ人々の数が主な要因である。さらに、コラーゲンベースの創傷ケア製品の需要増加や手術件数の増加が、同地域の成長を加速させる可能性が高い。
本レポートのために実施した一次インタビューは以下のように分類できる：

- 回答者別供給側70％、需要側30
- 回答者の役職別（供給側）：マネージャー - 45%、CXOおよびディレクター - 30%、エグゼクティブ - 25
- 地域別北米：40％、欧州：25％、アジア太平洋地域：20％、中南米：10％、中東・アフリカ：5
レポート掲載企業リスト
- インテグラ・ライフサイエンシズ（米国）
- DSM（オランダ）
- コルプラント・バイオテクノロジーズ社（イスラエル(イスラエル）
- 新田ゼラチン（日本）
- コラーゲンソリューションズ英国
- コラーゲンマトリックス社（米国）
- シマテーゼ（フランス）
- ゲリータAG（ドイツ）
- Tessenderlo Group ( BU PB Leiner ) （ベルギー）
- スミス・アンド・ネフュー（英国）
- ジムヴィ（米国）
- ジェラーゲン（英国）
- アドバンスト・バイオマトリックス（米）
- マトリセルGmbH（ドイツ）
- ルーセロット（オランダ）
- ワイシャールト（フランス）
- 廈門ハイファインゼラチン（中国）
- ガイストリッヒ製薬（スイス）
- シナヒール・ファーマシューティカルズ（インド）
- バイオリジェンテクノロジーズ（インド）
- メリルライフサイエンス（インド）
- メドスキン・スーベラック（ドイツ）
- Cologenesis Healthcare Pvt Ltd（インド）
- ダーマライト・インダストリーズLLC（米国）
- ユーケア・ファーマシューティカルズ・プライベート・リミテッド（インド）

調査範囲
この調査レポートは、コラーゲンとゼラチン市場の詳細な情報を提供しています。製品、用途、エンドユーザー、地域などの異なるセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの会社概要、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、コラーゲン・ゼラチン市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にします。
本レポートは、以下のポイントに関する洞察を提供します：
- コラーゲン・ゼラチン市場の成長に影響を与える主な促進要因（糖尿病、癌、慢性創傷の罹患率の増加、研究開発への資金・投資の増加、外科手術数の増加）、阻害要因（代替生体材料の入手可能性）、機会（21世紀治療法の実施）、課題（不十分な加工技術）の分析。
- 製品開発/イノベーション：コラーゲン・ゼラチン市場の新発売製品に関する詳細な洞察。
- 市場開発：有利な市場に関する包括的情報 - 当レポートでは、様々な地域のコラーゲン・ゼラチン市場を分析しています。
- 市場の多様化：コラーゲン・ゼラチン市場における新サービス、未開拓の地域、最近の開発、投資に関する詳細な情報。
- 競合評価：主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。Integra LifeSciences社（米国）、DSM社（オランダ）、CollPlant Biotechnologies Ltd.(イスラエル)、新田ゼラチン株式会社(日本)、コラーゲン・ソリューションズ社(英国)(英国）などがコラーゲン・ゼラチン市場に参入している。

ページTOPに戻る

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 MARKET SCOPE 30
1.3.1 YEARS CONSIDERED 30
1.4 CURRENCY CONSIDERED 31
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS 31
1.7 SUMMARY OF CHANGES 31
1.7.1 RECESSION IMPACT 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 COLLAGEN AND GELATIN MARKET: RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.2 PRIMARY DATA 35
FIGURE 2 COLLAGEN AND GELATIN MARKET: BREAKDOWN OF PRIMARIES 35
2.2 MARKET SIZE ESTIMATION 36
FIGURE 3 COLLAGEN AND GELATIN MARKET SIZE ESTIMATION, 2022 36
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 37
FIGURE 5 ILLUSTRATIVE EXAMPLE OF INTEGRA LIFESCIENCES: REVENUE SHARE ANALYSIS, 2022 37
2.2.1 INSIGHTS FROM PRIMARIES 39
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS 39
2.2.2 SEGMENTAL ASSESSMENT (BY SOURCE, APPLICATION, AND END USER): TOP-DOWN APPROACH 39
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 39
2.3 GROWTH RATE ASSUMPTIONS 40
FIGURE 8 COLLAGEN AND GELATIN MARKET: CAGR PROJECTIONS, 2023–2028 41
FIGURE 9 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 41
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 10 DATA TRIANGULATION METHODOLOGY 42
2.5 STUDY ASSUMPTIONS 43
2.6 RISK ANALYSIS 43
2.7 IMPACT OF RECESSION ON COLLAGEN AND GELATIN MARKET 43
TABLE 1 GLOBAL INFLATION RATE, 2021–2028 (%) 44
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 44
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 44
3 EXECUTIVE SUMMARY 45
FIGURE 11 COLLAGEN AND GELATIN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 45
FIGURE 12 COLLAGEN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46
FIGURE 13 GELATIN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46
FIGURE 14 COLLAGEN AND GELATIN MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 47
FIGURE 15 REGIONAL SNAPSHOT OF COLLAGEN AND GELATIN MARKET 48
4 PREMIUM INSIGHTS 49
4.1 GROWTH OPPORTUNITIES FOR PLAYERS IN COLLAGEN AND GELATIN MARKET 49
FIGURE 16 INCREASED PREVALENCE OF DIABETES AND CANCER TO DRIVE MARKET 49
4.2 COLLAGEN AND GELATIN MARKET IN NORTH AMERICA, BY SOURCE AND COUNTRY, 2022 50
FIGURE 17 BOVINE AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN COLLAGEN AND GELATIN MARKET, BY SOURCE AND COUNTRY, RESPECTIVELY, IN 2022 50
4.3 COLLAGEN AND GELATIN MARKET SHARE, BY SOURCE, 2023 VS. 2028 51
FIGURE 18 BOVINE SEGMENT TO DOMINATE MARKET IN 2028 51
4.4 COLLAGEN AND GELATIN MARKET SHARE, BY END USER, 2022 51
FIGURE 19 HOSPITALS SEGMENT HELD LARGER MARKET SHARE IN 2022 51
4.5 COLLAGEN AND GELATIN MARKET GROWTH OPPORTUNITIES, BY COUNTRY,
2023–2028 52
FIGURE 20 JAPAN TO REGISTER SECOND-HIGHEST CAGR IN COLLAGEN MARKET FROM 2023 TO 2028 52
FIGURE 21 CHINA TO EXHIBIT HIGHEST CAGR IN GELATIN MARKET DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 22 COLLAGEN AND GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
TABLE 4 COLLAGEN AND GELATIN MARKET: IMPACT ANALYSIS 55
5.2.1 DRIVERS 55
5.2.1.1 Increasing prevalence of diabetes & chronic wounds and cancer 55
5.2.1.2 Rising investments and funding in R&D of collagen and gelatin products 56
5.2.1.3 Growing number of surgical procedures 56
TABLE 5 NUMBER OF SURGERIES PERFORMED IN US, 2022–2023 57
5.2.2 RESTRAINTS 57
5.2.2.1 Availability of alternative biomaterials to collagen and gelatin 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Enforcement of 21st Century Cures Act 58
5.2.4 CHALLENGES 58
5.2.4.1 Lack of advanced manufacturing and marketing technologies 58
5.3 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PLAYERS IN COLLAGEN AND GELATIN MARKET 59
FIGURE 23 INCREASED USE OF COLLAGEN AND GELATIN PRODUCTS IN WOUND CARE AND SURGICAL PROCEDURES IS LIKELY TO HAVE POSITIVE IMPACT ON THE GROWTH OF THE MARKET 59
5.4 VALUE CHAIN ANALYSIS 59
FIGURE 24 COLLAGEN AND GELATIN MARKET: VALUE CHAIN ANALYSIS 60
5.5 SUPPLY CHAIN 60
FIGURE 25 SUPPLY CHAIN OF COLLAGEN & GELATIN MARKET 61
5.6 COLLAGEN AND GELATIN MARKET: ECOSYSTEM ANALYSIS 62
5.7 TECHNOLOGY ANALYSIS 62
5.8 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 6 COLLAGEN AND GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS 63
5.8.1 THREAT OF NEW ENTRANTS 63
5.8.2 THREAT OF SUBSTITUTES 63
5.8.3 BARGAINING POWER OF SUPPLIERS 63
5.8.4 BARGAINING POWER OF BUYERS 64
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 64
5.9 REGULATORY ANALYSIS 64
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
5.10 PATENT ANALYSIS 67
FIGURE 26 PATENTS GRANTED FOR COLLAGEN MARKET, JUNE 2013–JUNE 2023 67
5.10.1 LIST OF MAJOR PATENTS 67
FIGURE 27 PATENTS GRANTED FOR GELATIN MARKET, JUNE 2013–JUNE 2023 69
5.11 KEY CONFERENCES AND EVENTS, 2023–2024 70
TABLE 12 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 70
5.12 PRICING ANALYSIS 70
5.12.1 AVERAGE SELLING PRICE TREND ANALYSIS 70
TABLE 13 GELATIN MARKET: AVERAGE SELLING PRICE, BY SOURCE AND REGION, 2022–2023 (USD/KG) 71
TABLE 14 PORCINE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71
TABLE 15 BOVINE SKIN GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71
TABLE 16 BOVINE BONE GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 71
TABLE 17 FISH & POULTRY GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72
TABLE 18 OTHER ANIMAL SOURCES GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72
TABLE 19 PLANT-SOURCED GELATIN MARKET: AVERAGE SELLING PRICE, BY REGION, 2019–2023 (USD/KG) 72
5.13 PRICING ANALYSIS 72
5.13.1 AVERAGE SELLING PRICE TREND ANALYSIS 72
TABLE 20 BOVINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73
TABLE 21 PORCINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73
TABLE 22 POULTRY: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73
TABLE 23 MARINE: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 73
TABLE 24 PLANT SOURCES: AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2022 (USD/TON) 74
TABLE 25 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY MARKET PLAYERS, BY SOURCE, 2022 (USD/TON) 74
5.13.2 KEY STAKEHOLDERS IN BUYING PROCESS 74
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLLAGEN AND GELATIN PRODUCTS 74
5.13.3 BUYING CRITERIA 75
FIGURE 29 KEY BUYING CRITERIA FOR END USERS 75
6 COLLAGEN AND GELATIN MARKET, BY SOURCE 76
6.1 INTRODUCTION 77
TABLE 26 COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 77
TABLE 27 GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 77
6.2 BOVINE COLLAGEN AND GELATIN SOURCES 78
6.2.1 INCREASED USE IN TISSUE ENGINEERING APPLICATIONS TO DRIVE MARKET 78
TABLE 28 BOVINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 78
TABLE 29 NORTH AMERICA: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 30 EUROPE: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 31 ASIA PACIFIC: COLLAGEN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 32 BOVINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 80
TABLE 33 NORTH AMERICA: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 34 EUROPE: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 35 ASIA PACIFIC: GELATIN MARKET FOR BOVINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 82
6.3 PORCINE COLLAGEN AND GELATIN SOURCES 82
6.3.1 LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY OF PORCINE COLLAGEN AND GELATIN TO BOOST DEMAND 82
TABLE 36 PORCINE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 37 NORTH AMERICA: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 38 EUROPE: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 39 ASIA PACIFIC: COLLAGEN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 40 PORCINE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 41 NORTH AMERICA: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 42 EUROPE: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 43 ASIA PACIFIC: GELATIN MARKET FOR PORCINE SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 86
6.4 OTHER COLLAGEN AND GELATIN SOURCES 87
TABLE 44 OTHER SOURCES: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 45 NORTH AMERICA: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 46 EUROPE: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 47 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 48 OTHER SOURCES: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 49 NORTH AMERICA: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 50 EUROPE: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 51 ASIA PACIFIC: GELATIN MARKET FOR OTHER SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 91
7 COLLAGEN MARKET, BY APPLICATION 92
7.1 INTRODUCTION 93
TABLE 52 COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93
7.2 ORTHOPEDIC 93
7.2.1 INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE MARKET 93
TABLE 53 ORTHOPEDIC: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 54 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 55 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 56 ASIA PACIFIC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 95
7.3 WOUND CARE 96
7.3.1 RISING PREVALENCE OF CHRONIC WOUND CONDITIONS TO BOOST COLLAGEN ADOPTION 96
TABLE 57 WOUND CARE: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 58 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 59 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 60 ASIA PACIFIC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 98
7.4 DENTAL 98
7.4.1 RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET 98
TABLE 61 DENTAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 62 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 63 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 64 ASIA PACIFIC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 100
7.5 SURGICAL 101
7.5.1 INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY TO BOOST DEMAND FOR COLLAGEN PRODUCTS 101
TABLE 65 SURGICAL: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 66 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 67 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 68 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 103
7.6 CARDIOVASCULAR 103
7.6.1 GROWING USE OF COLLAGEN PATCHES TO IMPROVE HEART FUNCTION TO SUPPORT MARKET GROWTH 103
TABLE 69 CARDIOVASCULAR: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 70 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 71 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 72 ASIA PACIFIC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 105

7.7 OTHER APPLICATIONS 105
TABLE 73 OTHER APPLICATIONS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 74 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 75 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 76 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 107
8 GELATIN MARKET, BY APPLICATION 108
8.1 INTRODUCTION 109
TABLE 77 GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109
8.2 ORTHOPEDIC 109
8.2.1 USE OF GELATIN IN BONE AND CARTILAGE REGENERATION TREATMENT TO DRIVE MARKET 109
TABLE 78 ORTHOPEDIC: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 79 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 80 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 81 ASIA PACIFIC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.3 WOUND CARE 112
8.3.1 APPLICATION OF GELATIN-BASED HYDROGELS IN TREATING BURNS TO DRIVE MARKET 112
TABLE 82 WOUND CARE: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 83 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 84 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 85 ASIA PACIFIC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 114
8.4 OTHER APPLICATIONS 114
TABLE 86 OTHER APPLICATIONS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 87 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 88 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 89 ASIA PACIFIC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116

9 COLLAGEN AND GELATIN MARKET, BY END USER 117
9.1 INTRODUCTION 118
TABLE 90 COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 118
TABLE 91 GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 118
9.2 HOSPITALS 119
9.2.1 SIGNIFICANT USE OF BIOSURGERY PRODUCTS IN HOSPITALS 119
TABLE 92 HOSPITALS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 93 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 94 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 95 ASIA PACIFIC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 96 HOSPITALS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 97 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 98 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 99 ASIA PACIFIC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 123
9.3 SURGICAL CENTERS 123
9.3.1 AVAILABILITY OF HIGH-QUALITY AND LOW-COST MEDICAL SERVICES AT SURGICAL CENTERS 123
TABLE 100 SURGICAL CENTERS: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 101 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 102 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 103 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 104 SURGICAL CENTERS: GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 105 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 106 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 107 ASIA PACIFIC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 128
10 COLLAGEN AND GELATIN MARKET, BY REGION 129
10.1 INTRODUCTION 130
TABLE 108 COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 109 GELATIN MARKET, BY REGION, 2021–2028 (USD MILLION) 130
10.2 NORTH AMERICA 131
FIGURE 30 NORTH AMERICA: COLLAGEN MARKET SNAPSHOT 132
TABLE 110 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 111 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 133
TABLE 112 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 113 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 134
FIGURE 31 NORTH AMERICA: GELATIN MARKET SNAPSHOT 135
TABLE 114 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 115 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 136
TABLE 116 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
TABLE 117 NORTH AMERICA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 137
10.2.1 US 137
10.2.1.1 Increasing incidence of periodontitis and burn injuries to drive market 137
TABLE 118 US: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 138
TABLE 119 US: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 120 US: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 138
TABLE 121 US: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 139
TABLE 122 US: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 123 US: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 139
10.2.2 CANADA 140
10.2.2.1 Growing geriatric population and volume of surgeries to boost collagen and gelatin demand 140
TABLE 124 CANADA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 140
TABLE 125 CANADA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141
TABLE 126 CANADA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 141
TABLE 127 CANADA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 141
TABLE 128 CANADA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 129 CANADA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.2.3 RECESSION IMPACT ON MARKET IN NORTH AMERICA 142
10.3 EUROPE 143
TABLE 130 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 131 EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 143
TABLE 132 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 133 EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 144
TABLE 134 EUROPE: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 135 EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 145
TABLE 136 EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 137 EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.3.1 GERMANY 146
10.3.1.1 Increase in healthcare expenditure to boost adoption of collagen and gelatin products 146
TABLE 138 GERMANY: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 147
TABLE 139 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147
TABLE 140 GERMANY: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 147
TABLE 141 GERMANY: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 148
TABLE 142 GERMANY: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 143 GERMANY: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.3.2 UK 149
10.3.2.1 High risk of pressure ulcers in diabetic patients to drive market 149
TABLE 144 UK: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 149
TABLE 145 UK: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 146 UK: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 150
TABLE 147 UK: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 151
TABLE 148 UK: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 151
TABLE 149 UK: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.3.3 FRANCE 152
10.3.3.1 Well-established healthcare sector to provide lucrative opportunities to collagen and gelatin vendors 152
TABLE 150 FRANCE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 152
TABLE 151 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 152 FRANCE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 153
TABLE 153 FRANCE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 154
TABLE 154 FRANCE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 155 FRANCE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 154
10.3.4 REST OF EUROPE 155
TABLE 156 REST OF EUROPE: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 155
TABLE 157 REST OF EUROPE: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 158 REST OF EUROPE: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 156
TABLE 159 REST OF EUROPE: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 156
TABLE 160 REST OF EUROPE: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 161 REST OF EUROPE: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 157
10.3.5 RECESSION IMPACT ON MARKET IN EUROPE 157
10.4 ASIA PACIFIC 158
FIGURE 32 ASIA PACIFIC: COLLAGEN MARKET SNAPSHOT 159
TABLE 162 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 163 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 160
TABLE 164 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 165 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 161
FIGURE 33 ASIA PACIFIC: GELATIN MARKET SNAPSHOT 162
TABLE 166 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 167 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 163
TABLE 168 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 169 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 164
10.4.1 JAPAN 164
10.4.1.1 Rising geriatric population to support market growth 164
TABLE 170 JAPAN: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 165
TABLE 171 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 172 JAPAN: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 165
TABLE 173 JAPAN: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 166
TABLE 174 JAPAN: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 175 JAPAN: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 166
10.4.2 CHINA 167
10.4.2.1 Significant elderly population with diabetes to push demand for collagen and gelatin products 167
TABLE 176 CHINA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 167
TABLE 177 CHINA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 178 CHINA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 168
TABLE 179 CHINA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 168
TABLE 180 CHINA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 181 CHINA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 169
10.4.3 INDIA 169
10.4.3.1 Increasing healthcare spending by government to stimulate market growth 169
TABLE 182 INDIA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 170
TABLE 183 INDIA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 184 INDIA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 171
TABLE 185 INDIA: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 172
TABLE 186 INDIA: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 172
TABLE 187 INDIA: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.4.4 REST OF ASIA PACIFIC 173
TABLE 188 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 173
TABLE 189 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 190 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 174
TABLE 191 REST OF ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 174
TABLE 192 REST OF ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 193 REST OF ASIA PACIFIC: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 175
10.4.5 RECESSION IMPACT ON MARKET IN ASIA PACIFIC 175
10.5 REST OF THE WORLD (ROW) 175
TABLE 194 ROW: COLLAGEN MARKET, BY REGION, 2021–2028 (USD MILLION) 176
TABLE 195 ROW: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 176
TABLE 196 ROW: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 197 ROW: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 177
TABLE 198 ROW: GELATIN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 177
TABLE 199 ROW: GELATIN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 200 ROW: GELATIN MARKET, BY END USER, 2021–2028 (USD MILLION) 178
10.5.1 LATIN AMERICA 178
10.5.1.1 Increasing number of diabetic patients to rise demand for collagen and gelatin products 178
TABLE 201 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 179
TABLE 202 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 203 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 180
10.5.2 RECESSION IMPACT ON MARKET IN LATIN AMERICA 180
10.5.3 MIDDLE EAST & AFRICA 180
10.5.3.1 Growing focus on healthcare infrastructure improvement to drive market 180
TABLE 204 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY SOURCE, 2021–2028 (USD MILLION) 181
TABLE 205 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY END USER, 2021–2028 (USD MILLION) 181
10.5.4 RECESSION IMPACT ON MARKET IN MIDDLE EAST & AFRICA 182
11 COMPETITIVE LANDSCAPE 183
11.1 INTRODUCTION 183
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 183
FIGURE 34 COLLAGEN AND GELATIN MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 183
11.3 REVENUE SHARE ANALYSIS 184
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 184
11.4 MARKET SHARE ANALYSIS 184
FIGURE 36 COLLAGEN AND GELATIN MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 185
TABLE 206 COLLAGEN AND GELATIN MARKET: DEGREE OF COMPETITION 185
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 186
FIGURE 37 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 187
11.5.1 STARS 188
11.5.2 EMERGING LEADERS 188
11.5.3 PERVASIVE PLAYERS 188
11.5.4 PARTICIPANTS 188
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 189
11.6.1 PRODUCT FOOTPRINT OF 25 COMPANIES 189
TABLE 207 COLLAGEN AND GELATIN MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 189
11.6.2 REGIONAL FOOTPRINT OF 25 COMPANIES 190
TABLE 208 COLLAGEN AND GELATIN MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 190
11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES 191
FIGURE 38 COLLAGEN AND GELATIN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 191
11.7.1 PROGRESSIVE COMPANIES 192
11.7.2 STARTING BLOCKS 192
11.7.3 RESPONSIVE COMPANIES 192
11.7.4 DYNAMIC COMPANIES 192
11.8 COMPETITIVE BENCHMARKING OF START-UP/SMES 192
TABLE 209 COLLAGEN AND GELATIN MARKET: DETAILED LIST OF KEY START-UPS/SMES 192
TABLE 210 COLLAGEN AND GELATIN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 193
11.9 COMPETITIVE SCENARIOS AND TRENDS 194
11.9.1 PRODUCT LAUNCHES 194
TABLE 211 COLLAGEN AND GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023 194
11.9.2 DEALS 194
TABLE 212 COLLAGEN AND GELATIN MARKET: DEALS, JANUARY 2020–APRIL 2023 194
12 COMPANY PROFILES 195
12.1 KEY MARKET PLAYERS 195
(Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 INTEGRA LIFESCIENCES 195
TABLE 213 INTEGRA LIFESCIENCES: COMPANY OVERVIEW 195
FIGURE 39 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT 196
12.1.2 DSM 199
TABLE 214 ROYAL DSM: COMPANY OVERVIEW 199
FIGURE 40 DSM: COMPANY SNAPSHOT 200
12.1.3 NITTA GELATIN INC. 202
TABLE 215 NITTA GELATIN INC.: COMPANY OVERVIEW 202
FIGURE 41 NITTA GELATIN INC.: COMPANY SNAPSHOT 202
12.1.4 COLLPLANT BIOTECHNOLOGIES LTD. 204
TABLE 216 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW 204
FIGURE 42 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT 204
12.1.5 COLLAGEN SOLUTIONS PLC 207
TABLE 217 COLLAGEN SOLUTIONS PLC: COMPANY OVERVIEW 207
12.1.6 REGENITY 209
TABLE 218 REGENITY: COMPANY OVERVIEW 209
12.1.7 SYMATESE 211
TABLE 219 SYMATESE: COMPANY OVERVIEW 211
12.1.8 GELITA AG 212
TABLE 220 GELITA AG: COMPANY OVERVIEW 212
TABLE 221 GELITA AG: DEALS 213
12.1.9 TESSENDERLO GROUP (BU PB LINER) 214
TABLE 222 TESSENDERLO GROUP (BU PB LINER): COMPANY OVERVIEW 214
FIGURE 43 TESSENDERLO GROUP (BU PB LINER): COMPANY SNAPSHOT 215
TABLE 223 TESSENDERLO GROUP: DEALS 216
12.1.10 SMITH & NEPHEW PLC 217
TABLE 224 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 217
FIGURE 44 SMITH & NEPHEW PLC: COMPANY SNAPSHOT 218
12.1.11 ZIMVIE INC. 220
TABLE 225 ZIMVIE INC.: COMPANY OVERVIEW 220
12.1.12 JELLAGEN 221
TABLE 226 JELLAGEN: COMPANY OVERVIEW 221
TABLE 227 JELLAGEN: PRODUCT OFFERINGS 221
12.2 OTHER PLAYERS 222
12.2.1 ADVANCED BIOMATRIX 222
12.2.2 MATRICEL GMBH 223
12.2.3 ROUSSELOT 223
12.2.4 WEISHARDT 224
12.2.5 XIAMEN HYFINE GELATIN CO., LTD. 225
12.2.6 GEISTLICH PHARMA AG 226
12.2.7 SYNERHEAL PHARMACEUTICALS 227
12.2.8 BIOREGEN TECHNOLOGIES 228
12.2.9 MERIL LIFE SCIENCES PVT. LTD. 229
12.2.10 MEDSKIN SUWELACK 230
12.2.11 COLOGENESIS HEALTHCARE PVT LTD 231
12.2.12 DERMARITE INDUSTRIES, LLC 232
12.2.13 EUCARE PHARMACEUTICALS PRIVATE LIMITED 233
*Details on Business Overview, Products offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX 234
13.1 DISCUSSION GUIDE 234
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 238
13.3 CUSTOMIZATION OPTIONS 240
13.4 RELATED REPORTS 240
13.5 AUTHOR DETAILS 241

ページTOPに戻る

Table of Contents

Summary

The global collagen and gelatin market size is projected to reach USD 1.6 billion by 2028 from USD 1.2 billion in 2023, at a CAGR of 6.5% during the forecast period. Factors such as increased adoption of collagen and gelatin in wound care applications coupled with increased funding for collagen and gelatin research is driving the market growth. Increased number of cardiovascular surgeries is further likely to have positive impact on the market growth/
“The bovine segment held the dominant share in the collagen and gelatin market, by source, during the forecast period.”
Based on Source, the global collagen and gelatin market is segmented into bovine, porcine, and other sources. The Porcine segment accounted for the largest share in 2022. This is mainly due to the high its extensive use in tissue engineering and increased demand for biomaterials for wound care applications. Owing to various factors such as biocompatibility, structural support, moisture retention and other factors are increasing use of Bovine-based collagen products for various wound care applications.
“Orthopedic segment accounted for the largest share of the application segment in 2022.”
Based on application, the global collagen market is segmented into, wound care, dental, orthopedic, surgical, cardiovascular. The global gelatin market is segmented into orthopedic, wound care, and other applications. The orthopedic segment accounted for the largest share of the collagen and gelatin market in 2022. The dominance of the segment is attributable to the increased use of gelatin and collagen based products in various orthopedic surgeries and the increased demand for scaffolds.
“Asia Pacific region is likely to grow at a faster pace.”
The collagen and gelatin market is segmented into North America, , Asia Pacific, Europe and Rest of the World. Asia Pacific region is anticipated to grow at a significant CAGR. The growth of the region is majorly driven by the increasing prevalence of chronic wounds and the number of people suffering from chronic ulcers. Furthermore, increased adoption of demand for collagen-based wound care products and a rise in the number of surgeries is likely to upsurge the growth in the region.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side - 30%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:
• Integra LifeSciences (US)
• DSM (Netherlands)
• CollPlant Biotechnologies Ltd. (Israel)
• Nitta Gelatin Inc. (Japan)
• Collagen Solutions Ltd. (UK)
• Collagen Matrix, Inc. (US)
• Symatese (France)
• Gelita AG (Germany)
• Tessenderlo Group ( BU PB Leiner ) (Belgium)
• Smith & Nephew (UK)
• ZimVie (US)
• Jellagen (UK)
• Advanced BioMatrix (US)
• Matricel GmbH (Germany)
• Rousselot (Netherlands)
• Weishardt (France)
• Xiamen Hyfine Gelatin (China)
• Geistlich Pharma AG (Switzerland)
• Synerheal Pharmaceuticals (India)
• Bioregen Technologies (India)
• Meril LifeSciences (India)
• Medskin Suwelack (Germany)
• Cologenesis Healthcare Pvt Ltd (India)
• DermaRite Industries, LLC (US)
• Eucare Pharmaceuticals Private Limited (India)

Research Coverage:
This report provides a detailed picture of the Collagen and Gelatin market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall collagen and gelatin market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Growing incidence of diabetes, cancer, and chronic wounds, Rising funding and investments for R&D, Growing number of surgical procedures), restraints (Availability of alternate biomaterials), opportunities (Implementation of the 21st Century Cures Act), and challenges (Insufficient processing technologies) influencing the growth of collagen and gelatin market.
• Product Development/Innovation: Detailed insights on newly launched products of the collagen and gelatin market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the collagen and gelatin market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the collagen and gelatin market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players. Integra LifeSciences (US), DSM (Netherlands), CollPlant Biotechnologies Ltd. (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions Ltd. (UK), and among others in the collagen and gelatin market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（cardiovascular）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

コラーゲン・ゼラチン市場：供給源別（牛、豚、海産物）、用途別（創傷治療、整形外科、心臓血管、歯科、外科、神経修復）、エンドユーザー別（病院、外科センター）、地域別 - 2028年までの世界予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（cardiovascular）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?